16 November 2016 - PRESS INVITATION

Infection research experts meet in Cologne

Infectious diseases have recently kept making the headlines. Be it emerging epidemics like Ebola and Zika or the fight against increasing antibiotic resistance in bacteria—scientists and doctors are facing major challenges. The German Center for Infection Research (DZIF) Annual Meeting’s agenda once again has a broad spectrum of infectious diseases. The Meeting is taking place in the Flora Köln from 24 to 26 November.


Over 300 infection research experts will be presenting their latest infection research findings in Cologne. On Thursday, HIV and hepatitis are in the foreground; on Friday, the themes are hospital pathogens and antibiotic-resistant bacteria, gastrointestinal infections, infections in immunocompromised patients as well as the persisting global threat of tuberculosis and malaria. Saturday’s agenda includes Ebola and other emerging infectious diseases, as well the quest for new antibiotics which is increasingly becoming a race against time.

“At the DZIF, developing new antibiotics and vaccines constitute some of the most urgent goals,” emphasizes Prof Martin Krönke, Executive Board Chairman of the DZIF, “and the Annual Meeting’s programme highlights the DZIF’s broad range of infectious disease research topics.” The aim of the alliance is translation: rapidly implementing research findings into clinical practice.

We cordially invite all interested journalists to the meeting. The presentations will be held in English.

You can find the detailed Annual Meeting programme here. Please register at presse@dzif.de, if you would like to attend the conference. We will be happy to connect you with interview partners for your questions. Please inform us about your interview requests via e-mail by 21 November 2016.

German Center for Infection Research (DZIF) Annual Meeting

Date: 24 to 26 November 2016
Venue: Flora Köln, Am Botanischen Garten 1a, 50735 Cologne

At the German Center for Infection Research (DZIF), over 350 scientists from 35 institutions throughout Germany jointly develop new approaches to prevent, diagnose and treat infectious diseases. The aim is to translate research findings into clinical practice quickly and efficiently. With this, the DZIF paves the way to developing new vaccines, diagnostics and drugs against infections. The DZIF is funded by the BMBF and the federal states. You can find more information at www.dzif.de.

Contact for questions:

Janna Schmidt and Karola Neubert
German Center for Infection Research
Press Office
T +49 531 6181-1154/-1170


Back to List